Quick Search 
Drugs of Today
Register or sign in

  
 
  
Drugs Today 2007, 43(12): 841
ISSN 1699-3993
Copyright 2007 Clarivate Analytics
CCC: 1699-3993
DOI: 10.1358/dot.2007.43.12.1162079
 
 
An extract of timothy-grass pollen used as sublingual immunotherapy for summer hay fever
Kay, A.B.
 
 
Grazax(R) is a lyophilisate of an extract of Timothy-grass pollen (Phleum pratense) administered by the sublingual route to induce desensitization (or hyposensitization) to grass pollen in subjects with hay fever. Since allergen avoidance measures are limited in hay fever sufferers, present treatment, at least in the United Kingdom, is almost always by symptomatic medication. The effectiveness of symptomatic treatment in hay fever is variable and depends on patient compliance and the judicious prescribing of antihistamines and anti-inflammatory preparations either alone or in combination. Desensitization (hyposensitization or specific immunotherapy) by subcutaneous injection has been shown to be very efficacious and is used for patients who do not adequately respond to drug treatment. A rare side effect of desensitizing injections is anaphylaxis, and so use is limited to specialized centers. For these reasons there has been considerable interest in specific immunotherapy by the sublingual route. Grazax(R) has recently been approved in the United Kingdom. It is commenced at least four months prior to the expected start of the grass pollen season and in line with injection immunotherapy treatment will be recommended for a period of three years with annual reviews to assess patient outcomes. Grazax(R) grass allergen tablets are well tolerated in patients with grass pollen allergy with most adverse events being mild local reactions. There have been no instances of anaphylaxis. In randomized doubleblind placebo controlled trials Grazax(R) reduces symptoms and medication scores in adults with hay fever. The long-term effects of Grazax(R) are currently being investigated.


Full Text: HTMLPDF 
 
  



© Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy